Digital ischemic loss in systemic sclerosis

7Citations
Citations of this article
11Readers
Mendeley users who have this article in their library.

Abstract

Digital ischemic loss is a cause of significant morbidity in patients with systemic sclerosis (SSc). Microvascular disease with intimal proliferation and luminal narrowing of small digital arteries, as well as macrovascular disease with narrowing or occlusion of larger digital arteries, contribute to the perfusion defects involved in digital ischemic loss. Immediate clinical evaluation and treatment are mandatory at the onset of critical digital ischemia to prevent digital loss. Hospitalization for medical therapies including intravenous prostacyclin therapy should be considered for all SSc patients who present with critical digital ischemia. Surgical interventions are typically reserved for patients who fail medical therapies and for those with late stage, necrotic tissue. This paper summarizes the current knowledge regarding the risk factors, pathogenesis, evaluation, and treatment of digital ischemic loss in SSc. Copyright © 2010 Umaima Marvi and Lorinda Chung.

Cite

CITATION STYLE

APA

Marvi, U., & Chung, L. (2010). Digital ischemic loss in systemic sclerosis. International Journal of Rheumatology. https://doi.org/10.1155/2010/130717

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free